Navigation Links
New FASEB analysis documents impact of budget cuts on biomedical research
Date:5/17/2013

Bethesda, MD The Federation of American Societies for Experimental Biology (FASEB) released a new analysis of National Institutes of Health (NIH) funding trends highlighting the devastating impact of sequestration on the nation's capacity to support critical research. The FASEB analysis follows a May 15th Senate Appropriations Committee hearing featuring NIH Director, Francis Collins, MD, PhD, who testified that the $1.6 billion cut the agency sustained in FY 2013 due to sequestration is "having a substantial impact on the scientific community."

According to data from the NIH Website compiled by FASEB:

  • In constant dollars (adjusted for inflation), the NIH budget in FY 2013 is at its lowest level since FY 2000.

  • NIH awards are expected to drop from the 9,032 made in FY 2012 to an estimated 8,283 in FY 2013 (an 8.3 percent decrease).

A bipartisan group of senators joined Appropriations Committee Chair Barbara Mikulski (D-MD), Labor, Health and Human Services Subcommittee Chair Tom Harkin (D-IA) and subcommittee ranking member Jerry Moran (R-KS) in pledging to work together to do everything possible to increase the NIH budget in FY 2014.

FASEB urges Congress to restore the cuts and sustain the federal investment in NIH with a FY 2014 appropriation of at least $32 billion.


'/>"/>

Contact: Lawrence Green
lgreen@faseb.org
301-634-7335
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB 2013 Excellence in Science Award recipient announced
2. Undergraduate Student Summer Research Award recipients announced for the 2012 FASEB MARC summer research opportunity program
3. FASEB lauds Air India for transporting research animals
4. FASEB urges biomedical research community to speak out against sequestration
5. FASEB SRC announces conference: Gastrointestinal Tract XV: Epithelia, Microbes, Inflammation & Cancer
6. FASEB SRC announces conference registration open: The Biology of Calpains in Health and Disease
7. FASEB SRC announces: Mechanism and Regulation of Prokaryotic Transcription Conference
8. FASEB SRC announces conference: Renal Hemodynamics: Integrating with the Nephron & Beyond
9. FASEB SRC announces conference registration open for: Ciliate Molecular Biology
10. FASEB SRC announces conference registration open for: Mechanisms in Plant Development Conference
11. FASEB SRC announces conference registration open for: Hematologic Malignancies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/6/2017)... Jan. 6, 2017  Privately-held CalciMedica, Inc., announced ... healthy volunteers of a novel calcium release-activated calcium ... pancreatitis. Acute pancreatitis, sudden painful ... disorder, but can be very serious.  In severe cases ... where extended hospital stays, time in the ICU ...
(Date:1/4/2017)... VEGAS , Jan. 4, 2017  For the thousands of attendees ... a global leader in connected health and biometric measurement devices and services, ... monitors. On display in A&D Medical,s special CES Exhibit ... represent the ongoing expansion of the company,s WellnessConnected product platform.  ... ...
(Date:12/22/2016)... Calif. , Dec. 20, 2016  As part of ... 23andMe, the leading personal genetics company, recently released its latest ... . The book focuses on the topics of inheritance ... Generation Science Standards (NGSS) taught in elementary school classrooms in ... in a series by illustrator Ariana Killoran , whose ...
Breaking Biology News(10 mins):
(Date:1/20/2017)... , Jan. 20, 2017 Ginkgo ... of Gen9, a pioneer in the synthesis and ... unique expertise in assembling pathway-length synthetic DNA into ... and capacity in the construction of new organism ... industries. "Gen9 was founded to significantly ...
(Date:1/19/2017)... HOUSTON , Jan. 19, 2017 ... announced the formation of its Medical/Clinical Advisory Board. ... industry veterans who enhance the range and depth ... development of its novel prenatal diagnostic tests.  These ... and strategic guidance for the company,s product development ...
(Date:1/19/2017)... ANNAPOLIS, Md. and GAITHERSBURG, ... Inc. (NYSE MKT: PIP) and Altimmune, Inc., a ... the signing of a definitive agreement for the ... transaction. Altimmune,s current investors include Novartis Venture Fund, ... company will be a fully-integrated and diversified immunotherapeutics ...
(Date:1/19/2017)... ... January 19, 2017 , ... FireflySci Inc. is a go-getter type of ... growth is accounted to two main factors. The first is the amazing customer ... vendors supplying FireflySci products all around the world. , 2016 was a tremendous sales ...
Breaking Biology Technology: